ESC 365 - Angiotensin-neprilysin inhibition in acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials

ESC2025 Premium Access

Angiotensin-neprilysin inhibition in acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials

Session: New perspectives in cardiology (1) - Aggressive ways of saving patients

Topic: Pharmacotherapy

Speaker: Doctor M. Hunjul (Nablus, PS)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Marah Hunjul

Nablus (Palestine, State of)

0 follower

11 more presentations in this session

Discussant - Aggressive ways of saving patients

Prognostic significance of histological diagnosis in acute myocarditis with fulminant presentation

Speaker: Doctor Y. Takei (Tokyo, JP)

Novel semi-invasive pressure-volume loop analysis for hemodynamic assessment and risk stratification across SCAI stages in cardiogenic shock

Speaker: Doctor J. Ortega-Hernandez (Ciudad de Mexico, MX)

Impact of the combined use of VA-ECMO and impella (ECPELLA) on short-term mortality in cardiogenic shock patients receiving VA-ECMO: a propensity score-matched analysis

Speaker: Doctor T. Inamori (Kumamoto, JP)

Efficacy and safety of oral acetazolamide in patients with decompensated heart failure: hospital phase of open-label prospective randomized multicenter study ORION-A

Speaker: Professor I. Sabirov (Bishkek, KG)

Access the full session

New perspectives in cardiology (1) - Aggressive ways of saving patients

Speakers: Doctor M. Hunjul, Doctor Y. Takei, Doctor J. Ortega-Hernandez, Doctor T. Inamori, Professor I. Sabirov

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources